Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures (Natalie Breymeyer/Axios)

Natalie Breymeyer / Axios: Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures — Mithrl, an AI infrastructure company for biopharma, raised a $20 million Series A, CEO Vivek Adarsh tells Axios exclusively.